← Back to Clinical Trials
Recruiting NCT07547891

NCT07547891 Shear Wave Elastography for Evaluation of Hydronephrosis in Pregnancy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07547891
Status Recruiting
Phase
Sponsor Beni-Suef University
Condition Hydronephrosis
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2026-04-07
Primary Completion 2027-03

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Shear Wave Elastography (SWE)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 250 participants in total. It began in 2026-04-07 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Hydronephrosis is common during pregnancy and is often physiological; however, it may also result from true obstruction requiring intervention. Differentiating between physiological and obstructive hydronephrosis remains a clinical challenge using conventional ultrasound. This prospective observational study aims to evaluate the diagnostic accuracy of renal cortical stiffness measured by shear wave elastography (SWE) in differentiating obstructive from physiological hydronephrosis in pregnant women. Participants presenting with hydronephrosis will undergo clinical assessment, laboratory investigations, and ultrasound evaluation including SWE measurements. The diagnostic performance of SWE will be assessed using receiver operating characteristic (ROC) analysis, and optimal cut-off values will be determined. The study aims to provide a safe, non-invasive, and quantitative tool to improve diagnosis and guide management in pregnant patients with hydronephrosis.

Eligibility Criteria

* Inclusion Criteria: * Pregnant women ≥12 weeks gestation with Loin Pain. * Sonographic evidence of hydronephrosis. * Age ≥18 years. * Provided informed consent * Exclusion Criteria: * Chronic kidney disease (CKD). * Congenital renal anomalies. * Pre-eclampsia * Poor acoustic window. * Contraindication to examination position.

Contact & Investigator

Central Contact

Mahmoud Abdallah Mahmoud, lecturer of urology

✉ mahmoud.abdalla@med.bsu.edu.eg

📞 01155361979

Frequently Asked Questions

Who can join the NCT07547891 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Hydronephrosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07547891 currently recruiting?

Yes, NCT07547891 is actively recruiting participants. Contact the research team at mahmoud.abdalla@med.bsu.edu.eg for enrollment information.

Where is the NCT07547891 trial being conducted?

This trial is being conducted at Banī Suwayf, Egypt.

Who is sponsoring the NCT07547891 clinical trial?

NCT07547891 is sponsored by Beni-Suef University. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology